Adalimumab treatment optimization for psoriasis: Results of a long-term phase 2/3 Japanese study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Adalimumab treatment optimization for psoriasis: Results of a long-term phase 2/3 Japanese study

Published:2015-06-29 Issue:11 Volume:42 Page:1042-1052
ISSN:0385-2407
Container-title:The Journal of Dermatology
language:en
Short-container-title:J Dermatol

Author:

Asahina Akihiko¹,Ohtsuki Mamitaro²,Etoh Takafumi³,Gu Yihua⁴,Okun Martin M.⁴,Teixeira Henrique D.⁴,Yamaguchi Yuji⁴,Nakagawa Hidemi¹

Affiliation:

1. Department of Dermatology; The Jikei University School of Medicine; Tokyo Japan

2. Department of Dermatology; Jichi Medical University; Shimotsuke Japan

3. Division of Dermatology; Tokyo Teishin Postal Services Agency Hospital; Tokyo Japan

4. Global Pharmaceutical Research and Development; AbbVie; North Chicago Illinois USA

Funder

AbbVie

Publisher

Wiley

Subject

Dermatology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/1346-8138.13001/fullpdf

Reference15 articles.

1. Adalimumab in Japanese patients with moderate to severe chronic plaque psoriasis: efficacy and safety results from a Phase II/III randomized controlled study;Asahina;J Dermatol,2010

2. Efficacy, safety and medication cost implications of adalimumab 40 mg weekly dosing in patients with psoriasis with suboptimal response to 40 mg every other week dosing: results from an open-label study;Leonardi;Br J Dermatol,2012

3. Cigarette smoking, body mass index, and stressful life events as risk factors for psoriasis: results from an Italian case-control study;Naldi;J Invest Dermatol,2005

4. Obesity in psoriasis: the metabolic, clinical and therapeutic implications. Report of an interdisciplinary conference and review;Sterry;Br J Dermatol,2007

5. Prevalence of cardiovascular risk factors in patients with psoriasis;Neimann;J Am Acad Dermatol,2006

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dose escalation of biologic treatment in patients with moderate‐to‐severe psoriasis in Japan;Experimental Dermatology;2024-05

2. Adalimumab Dose Reduction and Withdrawal in Stable Non-Infectious Pediatric Uveitis: An Open-Label, Prospective, Pilot Study;Ocular Immunology and Inflammation;2024-04-23

3. A Systematic Review and Meta-Analysis of Injection Site Reactions in Randomized-Controlled Trials of Biologic Injections;Journal of Cutaneous Medicine and Surgery;2023-07

4. English version of Japanese guidance for use of biologics for psoriasis (the 2022 version);The Journal of Dermatology;2022-12-29

5. Real‐world, long‐term treatment patterns of commonly used biologics in Canadian patients with moderate‐to‐severe chronic plaque psoriasis;The Journal of Dermatology;2021-11-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3